Ophthalmic Antibiotics
Key Points
- Topical ophthalmic antibiotics treat bacterial conjunctivitis, keratitis, corneal ulcers, and blepharitis — and prevent infection after ocular surgery.
- Agent selection depends on the causative organism; fluoroquinolones (ciprofloxacin) and aminoglycosides (gentamicin) cover gram-negative organisms; erythromycin is first-line for simple bacterial conjunctivitis.
- Bacterial infections remain contagious for 24–48 hours after treatment begins — isolate eye secretions during this window.
- Erythromycin ophthalmic ointment is the only FDA-approved drug for neonatal eye prophylaxis (gonococcal and chlamydial ophthalmia neonatorum prevention).
- Contamination of the eyedropper tip is a leading cause of superinfection — patient education on sterile instillation technique is a critical nursing priority.
Mechanism of Action
Ophthalmic antibiotics work by disrupting bacterial cell wall synthesis or inhibiting protein synthesis, depending on the drug class. They are applied topically to achieve high local concentration in the conjunctiva and cornea while minimizing systemic absorption.
- Fluoroquinolones (ciprofloxacin): Inhibit bacterial DNA gyrase and topoisomerase IV → bactericidal activity against gram-negative organisms including Pseudomonas aeruginosa
- Aminoglycosides (gentamicin, neomycin): Interfere with bacterial protein synthesis → bactericidal primarily against aerobic gram-negative bacilli (E. coli, Klebsiella, Pseudomonas, Proteus)
- Macrolides (erythromycin): Inhibit bacterial protein synthesis → bacteriostatic; even drug remaining on eyelid provides therapeutic benefit via ointment contact
Drug Classes and Agents
| Drug | Route/Dose | Primary Indications |
|---|---|---|
| Ciprofloxacin 0.3% (Ciloxan) | 1–2 drops q2h (awake) × 2 days, then q4h × 5 days for conjunctivitis; intensive dosing for corneal ulcers | Bacterial conjunctivitis, corneal ulcers, Pseudomonas coverage |
| Erythromycin 0.5% (Ilotycin) | ~1 cm ointment in affected eye(s); neonates: 1 cm ointment once at delivery | Simple bacterial conjunctivitis; neonatal prophylaxis (GON) |
| Gentamicin sulfate | 1–2 drops q4h or ointment 2–3× daily | Conjunctivitis, keratitis, blepharitis, dacryocystitis, acute meibomianitis |
| Neomycin/Polymyxin B/Bacitracin | Per label × 7–10 days | Bacterial conjunctivitis, blepharitis; also available with dexamethasone or hydrocortisone for combined anti-infective/anti-inflammatory use |
| Ciprofloxacin 0.3%/Dexamethasone 0.1% (Ciprodex) | 4 drops twice daily × 7 days (otic-labeled; see otic formulation) | Combined coverage for infected inflammatory conditions |
Neonatal prophylaxis note: 1 cm ribbon of erythromycin 0.5% ointment is instilled in each eye within 1 hour of delivery to prevent gonococcal ophthalmia neonatorum (GON) and chlamydial ophthalmia, which can cause corneal scarring and blindness within 24 hours if untreated.
Nursing Assessment
NCLEX Focus
Contamination of the eyedropper or tube tip is a high-yield patient education point — touching the tip to any surface introduces bacteria and can cause secondary infection. Return-demonstration of drop instillation technique is the key nursing intervention before discharge.
Pre-administration:
- Assess visual acuity and document baseline ocular status
- Identify the specific infection type (conjunctivitis, keratitis, corneal ulcer) to confirm appropriate agent selection
- Review allergy history — cross-reactivity between topical and systemic fluoroquinolones/aminoglycosides is possible
Monitoring:
- Therapeutic response expected within 48 hours; absence of improvement warrants provider notification and possible culture
- Monitor for superinfection signs: worsening redness, increased purulent discharge, or new fungal symptoms with extended use
- Assess intraocular pressure in patients receiving combined antibiotic-corticosteroid preparations for more than 10 days — steroid component raises glaucoma risk
Nursing Interventions
- Drop instillation education: wash hands first; tilt head back, pull lower eyelid down to form a pocket; instill drop without touching tip to eye, lid, or lashes; close eye gently for 1–2 minutes; do not squeeze or blink vigorously
- Instruct patients to avoid wearing contact lenses during treatment; contacts should not be reinserted until the infection fully resolves
- Emphasize completing the full course even after symptoms improve — stopping early may result in resistance or relapse
- Isolation precautions: conjunctivitis is contagious; instruct patients not to share towels, pillows, or eye makeup during treatment and for 24–48 hours after starting therapy
Superinfection Risk
The risk of superinfection with ophthalmic antibiotics is high when eyedropper tips or ointment tube tips contact any surface. Counsel every patient explicitly on the no-touch technique — this is a critical safety teaching point that is frequently underemphasized.
Related Concepts
- assisting-with-sensory-deficits — Ophthalmic infections can temporarily impair vision; safety accommodation may be needed during treatment.
- eye-assessment-visual-acuity-and-common-abnormalities — Baseline and follow-up visual acuity assessment is essential in ocular antibiotic therapy.
- antibiotics — Systemic antibiotic principles including spectrum of activity, resistance, and superinfection apply to topical ophthalmic formulations.
- infection-control — Contact isolation measures and hand hygiene prevent spread of highly contagious bacterial conjunctivitis.
- atraumatic-care-and-developmentally-appropriate-communication — Pediatric and neonatal eye medication requires age-appropriate restraint and instillation technique.
Self-Check
- A nurse is preparing to instill erythromycin ointment in a newborn’s eyes after delivery. What is the purpose of this prophylaxis, and what condition does it prevent?
- A patient with bacterial conjunctivitis asks if they can return to work the next day after starting ciprofloxacin eye drops. What should the nurse advise?
- A patient’s eyedropper tip touched their cheek during drop instillation. What is the appropriate nursing response and follow-up education?